Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Poolbeg Pharma (POLB) Regulatory News

Date Source Headline
31st Aug 2022 7:25 am RNS Notice of Results
29th Jul 2022 7:00 am RNS Appointment of Joint Broker
20th Jul 2022 7:00 am RNS POLB001 human challenge clinical trial to commence
12th Jul 2022 2:06 pm RNS Second Price Monitoring Extn
12th Jul 2022 2:00 pm RNS Price Monitoring Extension
27th Jun 2022 7:00 am RNS Project update for AI model of RSV data
21st Jun 2022 4:40 pm RNS Second Price Monitoring Extn
21st Jun 2022 4:36 pm RNS Price Monitoring Extension
26th May 2022 2:05 pm RNS Second Price Monitoring Extn
26th May 2022 2:00 pm RNS Price Monitoring Extension
26th May 2022 7:00 am RNS US patents granted for POLB 001 and POLB 002
25th May 2022 4:40 pm RNS Second Price Monitoring Extn
25th May 2022 4:35 pm RNS Price Monitoring Extension
23rd May 2022 1:01 pm RNS TR-1: Notification of major interest in shares
12th May 2022 7:00 am RNS GMP manufacturing contract signed
11th May 2022 7:00 am RNS Attendance at European Melioidosis Congress
27th Apr 2022 7:00 am RNS Distribution in Specie update
14th Apr 2022 7:00 am RNS Key POLB 002 European Patent Granted
11th Apr 2022 7:00 am RNS Distribution in Specie Shareholders
4th Apr 2022 12:26 pm RNS Result of AGM
31st Mar 2022 7:00 am RNS POLB001 Update - Clinical Trial Agreement Signed
30th Mar 2022 7:00 am RNS Commencement of trading on US OTCQB market
24th Mar 2022 7:00 am RNS AI deal signed with CytoReason
9th Mar 2022 7:00 am RNS Notice of AGM
3rd Mar 2022 7:00 am RNS Final Results
28th Feb 2022 7:00 am RNS Notice of Results
24th Feb 2022 7:00 am RNS Artificial Intelligence deal with OneThree Biotech
31st Jan 2022 7:00 am RNS Confirmation of vaccine platform licence execution
17th Jan 2022 7:00 am RNS Exclusive license of RNA-based immunotherapy asset
16th Dec 2021 7:00 am RNS Poolbeg to develop oral vaccine delivery platform
6th Dec 2021 7:00 am RNS Poolbeg signs option for new vaccine candidate
25th Nov 2021 7:00 am RNS Scientific Advisory Board Appointment
18th Nov 2021 7:00 am RNS Update on POLB 001 Clinical Development
14th Oct 2021 9:05 am RNS Second Price Monitoring Extn
14th Oct 2021 9:00 am RNS Price Monitoring Extension
14th Oct 2021 7:00 am RNS PredictViral Patent Update
7th Oct 2021 7:00 am RNS RNA sequencing ahead of AI analysis programme
13th Sep 2021 7:00 am RNS September and October Investor conferences
7th Sep 2021 7:00 am RNS POLB001 US Patent Update
23rd Aug 2021 9:06 am RNS Second Price Monitoring Extn
FTSE 100 Latest
Value8,680.29
Change47.96